Financials data is unavailable for this security.
Cash flow in JPYView more
In 2023, Chordia Therapeutics Inc increased its cash reserves by 12.79%, or 544.08m. The company earned 543.73m from its operations for a Cash Flow Margin of 21.75%. In addition the company generated 345.00k from investing while cash from financing was even.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 58.88 |
---|---|
Tangible book value per share | 58.86 |
More ▼
Balance sheet in JPYView more
Current ratio | 24.76 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼